LEPU ScienTech Plans Key Meeting on Strategic Agreement
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced an extraordinary general meeting scheduled for December 10, 2024, to discuss and approve the Entrusted Products Related Framework Agreement with Lepu Medical. The resolution will address transactions and proposed annual caps through the end of 2027, seeking shareholder confirmation and authorization. This meeting is a crucial event for stakeholders as it influences the company’s strategic partnerships and financial outlook.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.